Form 8-K - Current report:
SEC Accession No. 0000950170-25-045231
Filing Date
2025-03-26
Accepted
2025-03-26 16:12:29
Documents
13
Period of Report
2025-03-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nktx-20250326.htm   iXBRL 8-K 68513
2 EX-99.1 nktx-ex99_1.htm EX-99.1 183211
3 GRAPHIC img220989892_0.jpg GRAPHIC 17177
  Complete submission text file 0000950170-25-045231.txt   408838

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nktx-20250326.xsd EX-101.SCH 26168
15 EXTRACTED XBRL INSTANCE DOCUMENT nktx-20250326_htm.xml XML 4705
Mailing Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 (925) 407-1049
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

EIN.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39370 | Film No.: 25773306
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)